Rutger M Schols1, Niels J Connell, Laurents P S Stassen. 1. Department of Surgery, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands, rutgermschols@hotmail.com.
Abstract
INTRODUCTION: Near-infrared fluorescence (NIRF) imaging, using contrast agents with fluorescent characteristics in the near-infrared (NIR: 700-900 nm) window, is considered to possess great potential for clinical practice in the future of minimally invasive surgery (MIS), given its capacity for intraoperative, real-time anatomical navigation, and identification. The aim of this review is to provide an overview of the literature concerning the current and potential future applications of fluorescence imaging in supporting anatomical guidance during MIS, and thereby guiding future research. METHODS: A systematic literature search was performed in the PubMed and Embase databases. All identified articles were screened and checked for eligibility by two authors. In addition, literature was sought by screening references of eligible articles. RESULTS: After administration of a fluorescent dye (e.g., indocyanine green), NIRF imaging can be helpful to improve the visualization of vital anatomical structures during MIS. Extra-hepatic bile ducts, arteries, ureters, sentinel lymph nodes, and lymph vessels have successfully been identified using NIRF imaging. A uniform approach regarding timing and route of dye administration has not yet been established. Optimization of both imaging systems and fluorescent dyes is needed to improve current shortcomings. New preclinical dyes are considered for optimization of NIRF imaging. CONCLUSION: Future implementation of new intraoperative optical methods, such as NIRF, could significantly contribute to intraoperative anatomy navigation and facilitate critical decision-making in MIS. Further research (i.e., large multi-center randomized controlled trials) is needed to establish the true value of this innovative optical imaging technique in standard clinical practice.
INTRODUCTION: Near-infrared fluorescence (NIRF) imaging, using contrast agents with fluorescent characteristics in the near-infrared (NIR: 700-900 nm) window, is considered to possess great potential for clinical practice in the future of minimally invasive surgery (MIS), given its capacity for intraoperative, real-time anatomical navigation, and identification. The aim of this review is to provide an overview of the literature concerning the current and potential future applications of fluorescence imaging in supporting anatomical guidance during MIS, and thereby guiding future research. METHODS: A systematic literature search was performed in the PubMed and Embase databases. All identified articles were screened and checked for eligibility by two authors. In addition, literature was sought by screening references of eligible articles. RESULTS: After administration of a fluorescent dye (e.g., indocyanine green), NIRF imaging can be helpful to improve the visualization of vital anatomical structures during MIS. Extra-hepatic bile ducts, arteries, ureters, sentinel lymph nodes, and lymph vessels have successfully been identified using NIRF imaging. A uniform approach regarding timing and route of dye administration has not yet been established. Optimization of both imaging systems and fluorescent dyes is needed to improve current shortcomings. New preclinical dyes are considered for optimization of NIRF imaging. CONCLUSION: Future implementation of new intraoperative optical methods, such as NIRF, could significantly contribute to intraoperative anatomy navigation and facilitate critical decision-making in MIS. Further research (i.e., large multi-center randomized controlled trials) is needed to establish the true value of this innovative optical imaging technique in standard clinical practice.
Authors: M Hutteman; J R van der Vorst; J S D Mieog; B A Bonsing; H H Hartgrink; P J K Kuppen; C W G M Löwik; J V Frangioni; C J H van de Velde; A L Vahrmeijer Journal: Eur Surg Res Date: 2011-06-30 Impact factor: 1.745
Authors: Stephan Jeschke; Lukas Lusuardi; Andy Myatt; Stephan Hruby; Christian Pirich; Guenter Janetschek Journal: Urology Date: 2012-09-15 Impact factor: 2.649
Authors: Nobuyuki Kosaka; Makoto Mitsunaga; Michelle R Longmire; Peter L Choyke; Hisataka Kobayashi Journal: Int J Cancer Date: 2011-06-18 Impact factor: 7.396
Authors: Ane Gerda Zahl Eriksson; Margaret Montovano; Anna Beavis; Robert A Soslow; Qin Zhou; Nadeem R Abu-Rustum; Ginger J Gardner; Oliver Zivanovic; Richard R Barakat; Carol L Brown; Douglas A Levine; Yukio Sonoda; Mario M Leitao; Elizabeth L Jewell Journal: Ann Surg Oncol Date: 2016-02-23 Impact factor: 5.344
Authors: Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch Journal: Med Phys Date: 2016-06 Impact factor: 4.071
Authors: Gloria Salvo; Pedro T Ramirez; Charles F Levenback; Mark F Munsell; Elizabeth D Euscher; Pamela T Soliman; Michael Frumovitz Journal: Gynecol Oncol Date: 2017-02-08 Impact factor: 5.482
Authors: Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert Journal: Nat Rev Clin Oncol Date: 2017-01-17 Impact factor: 66.675
Authors: Anning Li; Yue Wu; Jenny Linnoila; Benjamin Pulli; Cuihua Wang; Matthias Zeller; Muhammad Ali; Grant K Lewandrowski; Jinghui Li; Benoit Tricot; Edmund Keliher; Gregory R Wojtkiewicz; Giulia Fulci; Xiaoyuan Feng; Bakhos A Tannous; Zhenwei Yao; John W Chen Journal: Cancer Immunol Immunother Date: 2016-10-08 Impact factor: 6.968
Authors: Clare W Teng; Ahmad Amirshaghaghi; Steve S Cho; Shuting S Cai; Emma De Ravin; Yash Singh; Joann Miller; Saad Sheikh; Edward Delikatny; Zhiliang Cheng; Theresa M Busch; Jay F Dorsey; Sunil Singhal; Andrew Tsourkas; John Y K Lee Journal: J Neurooncol Date: 2020-09-10 Impact factor: 4.130